These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5997312)

  • 1. [Structural and function disorders provoked in the organism by helminth toxins].
    Savchuk NA; Savchuk OE
    Dokl Akad Nauk SSSR; 1966 Oct; 170(6):1466-9. PubMed ID: 5997312
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of parasitic worms' toxins on the nervous system in the host].
    Sawczuk M; Sawczuk O; Krutogolowa T
    Wiad Parazytol; 1971; 17(3):295-9. PubMed ID: 5116896
    [No Abstract]   [Full Text] [Related]  

  • 3. General pharmacology of the new antimuscarinic compound vamicamide.
    Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K
    Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
    Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS
    Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The actions of snake venoms on nerve and muscle. The pharmacology of phospholipase A and of polypeptide toxins.
    Meldrum BS
    Pharmacol Rev; 1965 Dec; 17(4):393-445. PubMed ID: 5322066
    [No Abstract]   [Full Text] [Related]  

  • 6. Tetrodotoxin, saxitoxin and their significance in the study of excitation phenomena.
    Kao CY
    Pharmacol Rev; 1966 Jun; 18(2):997-1049. PubMed ID: 5328391
    [No Abstract]   [Full Text] [Related]  

  • 7. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
    Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H
    Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
    Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H
    Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of erythrogenic toxins. II. Communication: in vivo biological activities of erythrogenic toxin produced by streptococcus pyogenes strain ny-5.
    Hríbalová V; Knöll H; Gerlach D; Köhler W
    Zentralbl Bakteriol A; 1980; 248(3):314-22. PubMed ID: 7013358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General pharmacology of recombinant human basic fibroblast growth factor.
    Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
    Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation, purification & pharmacodynamics of a toxin from the venom of the centipede Scolopendra subspinipes dehaani Brandt.
    Gomes A; Datta A; Sarangi B; Kar PK; Lahiri SC
    Indian J Exp Biol; 1983 Apr; 21(4):203-7. PubMed ID: 6662560
    [No Abstract]   [Full Text] [Related]  

  • 12. [The toxins of clostridia and their importance for the given disease].
    Micke H
    Med Monatsschr; 1968 Jan; 22(1):5-8. PubMed ID: 5707449
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biological characterization of the venom of the African spider, Phoneyusa lesserti Dresco. I. Action in vitro on the musculature of the gastrointestinal system].
    Arrigoni E; Fanfani A
    Farmaco Prat; 1974 Apr; 29(4):213-26. PubMed ID: 4827882
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on the lethal factor in the mouse submandibular gland].
    Abe I
    Josai Shika Daigaku Kiyo; 1984; 13(1):44-59. PubMed ID: 6596978
    [No Abstract]   [Full Text] [Related]  

  • 15. Toxicity studies on 1,1,2,2-tetrachloro-1,2-difluoroethane and 1,1,1,2-tetrachloro-2,2-difluoroethane.
    Clayton JW; Sherman H; Morrison SD; Barnes JR; Hood DB
    Am Ind Hyg Assoc J; 1966; 27(4):332-40. PubMed ID: 5967615
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect on tissue cultures of the toxins of Cl. perfringens types B, C, D, F].
    Shamraeva SA; Zemlianitskaia EP
    Zh Mikrobiol Epidemiol Immunobiol; 1967 Aug; 44(8):74-7. PubMed ID: 4306692
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pathogenesis of skin manifestations in helminthiasis].
    Triapichnikov PF
    Vestn Dermatol Venerol; 1978 Feb; (2):28-32. PubMed ID: 345668
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunogenicity of some staphylococcal antigens. II. Action of aggressin].
    Wysokińska T
    Med Dosw Mikrobiol; 1973; 25(1):13-20. PubMed ID: 4708464
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro heated guineapig skin toxin & its characterization.
    Bhatia B; Kapoor S; Saxena KC; Sharma RN
    Indian J Exp Biol; 1980 May; 18(5):521-3. PubMed ID: 7429565
    [No Abstract]   [Full Text] [Related]  

  • 20. [Metabolism of skin and changed induced by drugs, toxins and physical agents].
    Lawrence JC
    Recenti Prog Med; 1976 Mar; 60(3):233-60. PubMed ID: 1037415
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.